Drugs commonly used in kidney transplant patients not as effective as previously thought

October 22, 2015, Ottawa Hospital Research Institute

Kidney transplants saves lives and dramatically improve quality of life, but transplant recipients often must take dozens of pills a day to keep their new kidney functioning and prevent complications. Now, three new studies led by researchers at The Ottawa Hospital and the University of Ottawa show that three of these drugs are not nearly as effective as previously thought and may have serious side-effects. The results are expected to change medical practice around the world.

The most recent study, published in The Lancet Diabetes & Endocrinology on October 22, 2015, tested a drug called ramipril in patients with high levels of protein in the urine (which is considered a risk factor for kidney failure). The randomized, double-blinded trial included 212 patients from 14 centres in Canada and New Zealand and was funded by the Canadian Institutes of Health Research (CIHR).

After an average follow up of four years, there was no difference in key markers of kidney health among those who received the drug compared to those who received a placebo. In addition, patients who received ramipril were more likely to experience side-effects such as low blood counts (anemia), which can contribute to transplant failure and death.

"Ramipril lowers blood pressure, and previous research has shown that it reduces the risk of kidney failure in high-risk patients who have not had a transplant," explained Dr. Greg Knoll, co-lead author of the study and a kidney transplant specialist and scientist at The Ottawa Hospital and the University of Ottawa. "Many people assumed that ramipril would also help high-risk , so this drug has been commonly used in these patients despite limited evidence of benefit."

"Our study shows that ramipril provides no significant benefit to high-risk kidney transplant patients," concluded Dr. Dean Fergusson, co-lead author of the study and an epidemiologist and senior scientist at The Ottawa Hospital and the University of Ottawa. "We expect that this will change around the world and spare patients from taking unnecessary and potentially harmful medication."

The study comes on the heels of two similar studies also led by Drs. Knoll and Fergusson.

One, published in the Journal of the American Medical Association in November 2014, examined a drug called levofloxacin, which had been commonly used to prevent infection with the kidney transplant-related BK virus. The randomized, double-blinded trial included 154 transplant patients from seven Canadian centres and was funded by the CIHR. The results, summarized here, show that levofloxacin does not prevent BK virus infection, and in fact, is associated with a higher risk of developing antibiotic-resistant bacterial infections.

The last study, published in the British Medical Journal in November 2014, examined a drug called sirolimus, which suppresses the immune system and prevents transplant rejection. The challenge with many immune-suppressing drugs is that they can also increase the risk of cancer, but sirolimus was thought not to have this pitfall, so it was commonly prescribed to transplant patients with a high risk of cancer. Drs. Knoll and Fergusson conducted a meta-analysis of sirolimus in nearly 6,000 kidney transplant patients who participated in 21 trials around the world. The results, summarized here, show that while sirolimus does indeed lower the risk of cancer, patients who took the drug were 43% more likely to die overall. This study was funded by Pfizer.

"It's quite astounding that in the last year, we've found that three drugs commonly used in kidney transplant patients either don't work at all, or don't work nearly as well as we thought," said Dr. Knoll. "This shows how essential it is to conduct rigorous research to evaluate treatments."

"Taken together, these studies will save lives, improve quality of life and save the health care system money," said Dr. Fergusson. "They also open the door to research on new treatments that hopefully will provide more benefit to patients."

Jim Ward received a kidney transplant from his brother in 2001 and has participated in research led by Drs. Knoll and Fergusson at The Ottawa Hospital. "While it's disappointing to find these drugs do not work, it's only through research we can discover this information, and eventually prevent and eliminate kidney disease," he said.

Explore further: Use of antibiotic following kidney transplantation does not prevent virus infection

More information: The Lancet Diabetes & Endocrinology, www.thelancet.com/journals/lan … (15)00368-X/abstract

Related Stories

Use of antibiotic following kidney transplantation does not prevent virus infection

November 15, 2014
Among kidney transplant recipients, a 3-month course of the antibiotic levofloxacin following transplantation did not prevent the major complication known as BK virus from appearing in the urine. The intervention was associated ...

Age, not post-op infection, more important for kidney transplant success, study finds

September 22, 2015
Infection by virus cytomegalovirus (CMV) is a common and major complication following kidney transplantation. Previous studies have related CMV infection with increased kidney transplant failure and reduced patient survival. ...

Viral infection in transplant recipients increases risk of developing damaging antibodies

September 25, 2014
Kidney transplant recipients infected with BK virus are more likely to develop antibodies against their kidney transplants than uninfected patients, according to a study appearing in an upcoming issue of the Journal of the ...

Patients with a certain form of kidney disease may have a reduced risk of cancer

May 22, 2014
Patients with a certain form of kidney disease may have a reduced risk of cancer compared with patients with other kidney diseases, according to a study appearing in an upcoming issue of the Journal of the American Society ...

Transplant patients have high rate of cancer death

February 18, 2015
Researchers at the University of Adelaide are working to better understand how patients who receive life-saving organ transplants can be spared from dying of cancer many years later.

The link between drug therapy and kidney failure in transplant patients

September 11, 2015
New research will help scientists and medical professionals to better understand the long-term complications caused by an immunosuppressant drug used to treat thousands of kidney transplant patients.

Recommended for you

High gluten diet in pregnancy linked to increased risk of diabetes in children

September 19, 2018
A high gluten intake by mothers during pregnancy is associated with an increased risk of their child developing type 1 diabetes, suggests a study published by The BMJ today.

Anti-inflammatory protein promotes healthy gut bacteria to curb obesity

September 19, 2018
Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported ...

Study reveals the current rates of diagnosed type 1 and type 2 diabetes in American adults

September 18, 2018
A new study from the University of Iowa finds that type 2 diabetes remains overwhelmingly the most common type of diabetes diagnosed in American adults who have the disease.

Research reveals link between immunity, diabetes

September 14, 2018
When it comes to diet-induced obesity, your immune system is not always your friend.

BPA exposure in U.S.-approved levels may alter insulin response in non-diabetic adults

September 14, 2018
In a first study of its kind study, researchers have found that a common chemical consumers are exposed to several times a day may be altering insulin release. Results of the study, led by scientists at the University of ...

High blood sugar during pregnancy ups risk of mother's type 2 diabetes, child's obesity

September 11, 2018
Mothers with elevated blood glucose during pregnancy—even if not high enough to meet the traditional definition of gestational diabetes—were significantly more likely to have developed type 2 diabetes a decade after pregnancy ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.